Source: Journal of Endocrinological Investigation. Unidade: FM
Subjects: ACROMEGALIA (TERAPIA), SOMATOSTATINA (APLICAÇÕES TERAPÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASARINI, A. P. M. et al. Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: Preferential expression of somatostatin receptor subtype 3. Journal of Endocrinological Investigation, v. 29, n. 9, p. 826-830, 2006Tradução . . Disponível em: https://doi.org/10.1007/bf03347378. Acesso em: 21 maio 2024.APA
Casarini, A. P. M., Pinto, E. M., Jallad, R. S., Giannella Neto, D., & Bronstein, M. D. (2006). Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: Preferential expression of somatostatin receptor subtype 3. Journal of Endocrinological Investigation, 29( 9), 826-830. doi:10.1007/bf03347378NLM
Casarini APM, Pinto EM, Jallad RS, Giannella Neto D, Bronstein MD. Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: Preferential expression of somatostatin receptor subtype 3 [Internet]. Journal of Endocrinological Investigation. 2006 ; 29( 9): 826-830.[citado 2024 maio 21 ] Available from: https://doi.org/10.1007/bf03347378Vancouver
Casarini APM, Pinto EM, Jallad RS, Giannella Neto D, Bronstein MD. Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: Preferential expression of somatostatin receptor subtype 3 [Internet]. Journal of Endocrinological Investigation. 2006 ; 29( 9): 826-830.[citado 2024 maio 21 ] Available from: https://doi.org/10.1007/bf03347378
